{"id":"W4412156841","doi":"10.1080/09513590.2025.2526560","title":"Targeting vasomotor symptoms with the new drug fezolinetant – an expert overview","year":2025,"lang":"en","type":"review","venue":"Gynecological Endocrinology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma; Astellas Pharma Canada","keywords":"Vasomotor; Drug; Medicine; Pharmacology; Intensive care medicine; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006761153,0.0007439872,0.001235627,0.002315565,0.0002535199,0.0008929137,0.0009426115,0.001147037,0.00412086],"category_scores_gemma":[0.0009621951,0.000281258,0.001019959,0.001492028,0.0003192538,0.001131209,0.0004719475,0.001715777,0.001252089],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005111551,"about_ca_system_score_gemma":0.0009967079,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001182651,"about_ca_topic_score_gemma":0.002493588,"domain_scores_codex":[0.9997845,0.00003723195,0.00004396469,0.00004300158,0.00007051273,0.00002068941],"domain_scores_gemma":[0.9995316,0.000296022,0.00005467774,0.000009174766,0.000085999,0.00002253234],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001325663,0.00009041554,0.0001613165,0.04982616,0.0001887875,0.0002243668,0.00007150548,0.0002888528,0.000962445,0.002168653,0.02559021,0.9202948],"study_design_scores_gemma":[0.00005887086,0.0002125523,0.0009967835,0.0223454,0.000498303,0.002159891,0.00008530931,0.0001808982,0.0005045797,0.001886311,0.9710406,0.00003057931],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008292861,0.9990156,0.00005687682,0.0002216248,0.0001359616,0.000005828063,0.00001475186,0.000004514014,0.0004618598],"genre_scores_gemma":[0.0005467947,0.998749,0.0001416021,0.0001813775,0.0001069478,0.000008323768,0.00002436159,0.000001089287,0.0002403827],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00412086,"threshold_uncertainty_score":0.01378566,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04869777701113861,"score_gpt":0.3541745581446406,"score_spread":0.305476781133502,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}